Data / Form D filings / BRIDGE PHARMACEUTICALS, INC.
BRIDGE PHARMACEUTICALS, INC.: Form D filing
BRIDGE PHARMACEUTICALS, INC., a pharmaceuticals company in Gaithersburg, MD, filed a Form D with the SEC in 2009. The latest, on August 7, 2009, reports $2.2 million sold of a $4.3 million offering to 5 investors.
Find out what BRIDGE PHARMACEUTICALS, INC. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 610 Professional Dr., Gaithersburg, MD, 20879
- Phone
- (240) 364-6300
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Cayman Islands
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1363234
The full lists. Form D filings in Maryland: 608 rows, $30.40, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 7, 2009 | New notice | $4,335,009 | $2,188,388 | $2,146,621 | 5 | Jul 24, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Thomas Oakley | Executive Officer, Director | |
| Anthony Sun | Director | |
| Patrik Jeanmonod | Executive Officer | |
| Helen Wong | Director | |
| Thomas J. De Loia | Executive Officer | |
| Vincent Lagrotteria | Executive Officer | |
| Carlos Orantes | Executive Officer | |
| Ronald Marler | Executive Officer, Director | |
| "Charles ""Jiggs""" Davis | Director | |
| Dennis Purcell | Director |
Every Form D from the week of Aug 3, 2009 · All recent filings in Maryland · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what BRIDGE PHARMACEUTICALS, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.